LOCALLY ADVANCED SOLID TUMORS
Clinical trials for LOCALLY ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: experimental drug targets genetic flaws
Disease control Recruiting nowThis study is testing a new drug called repotrectinib in children and young adults (up to age 25) with advanced or spreading cancers that have specific genetic changes (ALK, ROS1, or NTRK). The first part aims to find a safe dose. The second part will see if the drug can shrink t…
Matched conditions: LOCALLY ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First patients receive new experimental cancer drug in early safety trial
Disease control Recruiting nowThis is a first-in-human study to test the safety, side effects, and best dose of a new investigational drug called RO7566802. It will be given alone and in combination with an existing immunotherapy drug (atezolizumab) to up to 250 adults with advanced solid tumors that have spr…
Matched conditions: LOCALLY ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC